Utilizing Neoadjuvant Immunotherapies In Patients With Er+, Her2- Primary Breast Cancer

Utilizing neoadjuvant immunotherapies in patients with ER+, HER2- primary breast cancer

Neoadjuvant Therapy for HER2-positive Breast Cancer - Dr. Scott Christensen

HER2 In Breast Cancer: Testing Guidelines and New Treatment Approaches

ASCP

Adjuvant/Neoadjuvant Therapy for Breast Cancer: Updates and Molecular Predictors of Benefit

Adjuvant Therapy | 2023 Best of Breast Conference

Total Health | Oncology

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast Cancer

PeerView Oncology

Neoadjuvant chemotherapy for breast cancer - Time to rethink. 27Jul22

NEOS: prognosis of ER+ breast cancer pts who received neoadjuvant ET with/without adjuvant chemo

ALTERNATE: neoadjuvant endocrine treatment in ER+/HER2- breast cancer

Latest advances in immuno-oncology research in ER+ breast cancer

CheckMate 7FL: nivo vs PBO in high-risk ER+ HER2- BC with neoadjuvant chemo and adjuvant therapy

ALTERNATE: neoadjuvant chemotherapy in ER+ HER2- breast cancer

EMERALD: elacestrant vs. SOC for patients with ER+ HER2- metastatic breast cancer

Study of Immunotherapy Combinations for Patients with HER2-Positive Metastatic Breast Cancer

Dana-Farber Cancer Institute

Immunotherapy in the Neoadjuvant Management of HER2-Positive Breast Cancer

Overview of Neoadjuvant Therapy in HER2+ Breast Cancer

Dr. Khong on the Benefit of Neoadjuvant Endocrine Therapy in ER+ Breast Cancers

Treatment Updated for HER2 Positive Breast Cancer: Changing Paradigms

Total Health | Oncology

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. Schwartzberg

Total Health | Oncology

HER2 Positive Breast Cancer: Everything You Must Know

Breast Cancer School for Patients